ÂÜÀòÂÒÂ×

Ewa Terczynska-Dyla has a diverse work experience in the field of scientific research. Ewa is currently working at ALK as a Lead Scientist since May 2023. Before that, they worked at LEO Pharma as a Drug Discovery Scientist from September 2021 to April 2023. Ewa also worked as a Postdoctoral Research Fellow at Aarhus University, where they studied autoimmune diseases and investigated a novel mutation in the AICDA gene from September 2018 to December 2021. Prior to that, they served as a Postdoctoral Research Fellow and a PhD student at Aarhus University, focusing on lymphocyte biology. Ewa also gained experience as a Graduate Intern at the Singapore Immunology Network, completed a Master's program at Jagiellonian University, and was an UREKA Intern at Dublin Institute of Technology. Ewa participated in an Erasmus Exchange program at Aarhus University in Denmark and also had an internship at Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology.

Ewa Terczynska-Dyla earned a Master of Science (M.Sc.) in Biotechnology from Jagiellonian University in the years 2006-2011. Ewa then went on to pursue a Doctor of Philosophy (Ph.D.) in Molecular Biology and Genetics at Aarhus University, which they completed between 2012 and 2015. Additionally, they obtained a certification in Project Management 1 from Mannaz | Kurser, uddannelser og konsulentydelser, although the specific month of obtaining the certification is not provided.